The negative effect of AT56 on cell invasion was demonstrated and AT56 was observed to dose-dependently decrease the expression of zeb1 and vimentin in DLBCL cells (Fig. 3I and J). The gene discussed is VIM; the disease is diffuse large B-cell lymphoma.